Verastem, Inc. Equity-NMS: VSTM

$3.9 -0.06 (December 25, 2024)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$3.96
Open :$3.94
Today's high :$3.98
Today's low :$3.84
52W low :$2.1
52W high :$14.22
1Y :255.73%
5Y :238.35%
EPS(TTM): :-3.14
Shares O/S :44.51 M
Market cap :173.58 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Verastem, Inc. today?

Verastem, Inc. (VSTM) share price as of December 25, 2024, is $4. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Verastem, Inc.?

Yes, Indian Investors can invest in the Verastem, Inc. (VSTM) Share by opening an international trading account with Angel One.

How can I purchase Verastem, Inc. shares in India?

Purchasing Verastem, Inc. (VSTM) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Verastem, Inc. (VSTM) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Verastem, Inc.?

Yes, you can purchase fractional shares of Verastem, Inc. (VSTM) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Verastem, Inc.?

The market capitalization of Verastem, Inc. on December 25, 2024, is $101.3 M.

In which sector Verastem, Inc. belongs?

Verastem, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Verastem, Inc. stocks?

In order to invest in Verastem, Inc. (VSTM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Verastem, Inc.

Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).